Amahit, Hyde M.

HRN: 25-01-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2024
CEFUROXIME 500MG (TAB)
05/28/2024
06/04/2024
PO
500mg
BID X 7 Days
UTI
Waiting Final Action 
05/30/2024
CEFUROXIME 1.5GM (VIAL)
05/30/2024
05/30/2024
IV
1.5 G
Loading Ptor
For Stat CS
Waiting Final Action 
05/30/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2024
06/05/2024
IV
900 Mg
Q8
Sp LTCS, Thickly Msaf
Waiting Final Action 
05/30/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/30/2024
06/05/2024
IV
240 Mg
OD
Sp LTCS
Waiting Final Action 
05/30/2024
CEFUROXIME 500MG (TAB)
05/30/2024
06/05/2024
ORAL
500mg
BID
Sp LTCS
Waiting Final Action 
05/30/2024
MUPIROCIN 2%, 15G (TUBE)
05/30/2024
06/05/2024
SKIN
Aply On Suture Site
Bid
Sp LTCS
Waiting Final Action 
05/30/2024
MUPIROCIN 2%, 15G (TUBE)
05/30/2024
06/05/2024
SKIN
Apply On Affected Area
OD
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: